Pathway,Score
Signaling by VEGF,0.07682721530089719
Negative regulation of the PI3K/AKT network,-0.004995868727889586
PI3K/AKT Signaling in Cancer,0.06496540421306762
G beta:gamma signalling through PI3Kgamma,0.04569417251577449
G-protein beta:gamma signalling,-0.014516240732528796
VEGFA-VEGFR2 Pathway,0.014945151281871965
VEGFR2 mediated vascular permeability,0.008714770374281833
Constitutive Signaling by AKT1 E17K in Cancer,0.015557947136612127
Respiratory Syncytial Virus Infection Pathway,0.032483534212388074
RSV-host interactions,0.004209590566872601
RHO GTPases Activate WASPs and WAVEs,-0.013368765644469092
RAC2 GTPase cycle,0.017642337679309294
RAC3 GTPase cycle,-0.045751354911884534
Parasite infection,0.07156455260268375
Leishmania phagocytosis,-0.005084346186810411
FCGR3A-mediated phagocytosis,0.007376057763665057
Signaling by NOTCH1,-0.014927478626213962
NOTCH1 Intracellular Domain Regulates Transcription,-0.012875576072273003
Signaling by NOTCH1 PEST Domain Mutants in Cancer,0.019397766948227504
Signaling by NOTCH1 in Cancer,0.02355347527886342
Constitutive Signaling by NOTCH1 PEST Domain Mutants,-0.039355040597059486
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,-0.05614390589383248
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,-0.0001153497990817595
Regulation of PTEN gene transcription,0.03615130205184193
Budding and maturation of HIV virion,0.028951403217194166
Uptake and actions of bacterial toxins,0.011245720069140444
Bacterial Infection Pathways,-0.03389622106300563
NRAGE signals death through JNK,-0.0009228991484108075
p75 NTR receptor-mediated signalling,-0.004574339659868705
"Cell death signalling via NRAGE, NRIF and NADE",0.03524935145506993
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,0.00447648881550748
Neurodegenerative Diseases,0.03130297039156733
Diseases of programmed cell death,0.07506943702454286
Defective Intrinsic Pathway for Apoptosis,-0.019216004542684427
Signaling by SCF-KIT,-0.019048244963830733
Regulation of KIT signaling,0.04890764571927557
Degradation of beta-catenin by the destruction complex,-0.015389573286376272
Beta-catenin phosphorylation cascade,0.005355588708083836
Disassembly of the destruction complex and recruitment of AXIN to the membrane,0.000546733174450098
G alpha (12/13) signalling events,0.08361156215458329
Pre-NOTCH Transcription and Translation,-0.07362134547887425
Pre-NOTCH Expression and Processing,-0.08459104947210452
Signaling by NOTCH2,-0.024367027574213714
NOTCH2 intracellular domain regulates transcription,-0.07490933641119399
Signaling by NOTCH3,0.038956025990735645
NOTCH3 Intracellular Domain Regulates Transcription,-0.028359824474543195
Signaling by NOTCH4,-0.015711843779845802
NOTCH4 Intracellular Domain Regulates Transcription,-0.00360692048265178
Signaling by MET,0.05005797528191999
RAS processing,0.018040391402448085
Potential therapeutics for SARS,-0.026690351299707097
Host Interactions of HIV factors,-0.07837383873850905
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,0.006825731888325603
The role of Nef in HIV-1 replication and disease pathogenesis,0.028008122415620788
NR1H2 and NR1H3-mediated signaling,-0.0010742429905414893
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,0.1236524756987617
Diseases of glycosylation,0.022014325239503606
Diseases associated with O-glycosylation of proteins,0.008891867243011992
Defective GALNT3 causes HFTC,-0.025697677752119664
Defective GALNT12 causes CRCS1,0.0249467252665192
Diseases of metabolism,0.015640290775822838
Diseases of DNA repair,0.03341189528302449
Diseases of DNA Double-Strand Break Repair,-0.02023249746305278
Defective homologous recombination repair (HRR) due to BRCA2 loss of function,-0.03514373440029102
Defective homologous recombination repair (HRR) due to BRCA1 loss of function,-0.003404762170155797
Defective homologous recombination repair (HRR) due to PALB2 loss of function,-0.01957714525034136
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function,-0.0014424528246579668
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function,-0.005054170302367212
Impaired BRCA2 binding to RAD51,0.019414507515170376
Impaired BRCA2 binding to PALB2,0.028073001479055476
Effects of PIP2 hydrolysis,-0.014422361083817656
Integrin signaling,0.0003834214369138332
Retrograde neurotrophin signalling,-0.0007214571469468225
Signaling by NTRK1 (TRKA),-0.07941666206198683
TNFR1-induced proapoptotic signaling,-0.009420936422242157
Regulation of TNFR1 signaling,-0.056187408673392926
TNFR1-induced NF-kappa-B signaling pathway,0.03156949602975239
TNF signaling,0.024829003257153575
RHOA GTPase cycle,0.02043309515915231
SARS-CoV-2 activates/modulates innate and adaptive immune responses,0.008904282433422128
HCMV Infection,-0.008676131487691155
HCMV Early Events,-0.0057717256458909945
Regulation of RAS by GAPs,-0.016313015953736784
RHOF GTPase cycle,-0.05587464150544116
P2Y receptors,-0.013446657898030977
Nucleotide-like (purinergic) receptors,0.0016969067444544065
Signaling by PTK6,-0.0023660063523907576
Signaling by Non-Receptor Tyrosine Kinases,0.013013810150555756
Signaling by Retinoic Acid,-0.06961322779320976
RA biosynthesis pathway,-0.047221330379616525
Signaling by ERBB2,-0.002334449563108582
Downregulation of ERBB2 signaling,0.03370735192932319
Activated NOTCH1 Transmits Signal to the Nucleus,0.03236365297087934
NOTCH2 Activation and Transmission of Signal to the Nucleus,0.15045894977351773
NOTCH3 Activation and Transmission of Signal to the Nucleus,0.030609728368784065
Opioid Signalling,-0.016341911447433383
DARPP-32 events,0.0429925644851909
Nuclear Events (kinase and transcription factor activation),-0.0487266178261221
Signaling by NTRK2 (TRKB),-0.045610698659023
NGF-stimulated transcription,-0.003973207570938042
Class B/2 (Secretin family receptors),0.05588237541607068
G alpha (s) signalling events,-0.022149213671209898
RHOB GTPase cycle,-0.008717699637196033
RHOC GTPase cycle,-0.02806306495133447
Vpu mediated degradation of CD4,0.008843767989879599
Vif-mediated degradation of APOBEC3G,-0.02189095721447984
PCP/CE pathway,-0.05365488304354172
Asymmetric localization of PCP proteins,0.023766322248440237
Degradation of AXIN,0.06149540520994909
Degradation of DVL,-0.002091901792261149
Hedgehog ligand biogenesis,-0.08118992062906856
Hh mutants are degraded by ERAD,0.004502627552370644
Hh mutants abrogate ligand secretion,0.0026525662545353167
Degradation of GLI1 by the proteasome,0.002836766018390615
Degradation of GLI2 by the proteasome,-0.01060088430188082
GLI3 is processed to GLI3R by the proteasome,-0.0317204939693309
Hedgehog 'off' state,-0.01653107657472652
ABC transporter disorders,-0.003619863046396672
Disorders of transmembrane transporters,-0.006856803770603334
Hedgehog 'on' state,0.19145244651160426
Defective CFTR causes cystic fibrosis,0.35357620807776785
MAPK6/MAPK4 signaling,0.09455527496907398
Regulation of PTEN stability and activity,-0.03687141670907004
Negative regulation of NOTCH4 signaling,0.01750862210531578
Formation of HIV elongation complex in the absence of HIV Tat,-0.021388035765256993
Formation of the HIV-1 Early Elongation Complex,-0.02790973954607442
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,-0.01681309050880603
HIV Transcription Initiation,0.007799019816539411
RNA Polymerase II HIV Promoter Escape,-0.009484461643267831
HIV Transcription Elongation,-0.017894779742570182
Transcription of the HIV genome,0.024721688139942816
Formation of HIV-1 elongation complex containing HIV-1 Tat,-0.013442716373592983
Tat-mediated elongation of the HIV-1 transcript,-0.03796589372400574
RHOBTB3 ATPase cycle,0.017954663449300707
Signaling by TGF-beta Receptor Complex,0.2680609121702224
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,-0.009301627618107138
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,-0.004501842886650131
Pausing and recovery of Tat-mediated HIV elongation,0.00428166148805425
Tat-mediated HIV elongation arrest and recovery,-0.053637230891857006
HIV elongation arrest and recovery,-0.0030824463848484573
Pausing and recovery of HIV elongation,-0.0194854824119064
Estrogen-dependent gene expression,0.005563585036937165
RHOBTB2 GTPase cycle,0.07929866367708868
RHOBTB1 GTPase cycle,0.06277773912293831
RHOBTB GTPase Cycle,-0.0596093859715376
Signaling by EGFR,0.0021922708598339806
EGFR downregulation,-0.008759677143473222
Signaling by FGFR,0.20442114950179804
Negative regulation of FGFR1 signaling,0.00028904293999870744
Negative regulation of FGFR2 signaling,-0.012956062704440767
Negative regulation of FGFR3 signaling,-0.01706478311831187
Negative regulation of FGFR4 signaling,0.07158325693955946
Signaling by FGFR1,0.034297358633609436
Signaling by FGFR2,0.04932835292169446
Signaling by FGFR3,-0.01644246046535449
Signaling by FGFR4,0.03782408053610373
Negative regulation of MET activity,-0.011329320052406005
InlB-mediated entry of Listeria monocytogenes into host cell,0.08919137850534305
Listeria monocytogenes entry into host cells,0.013968733097011054
RHOU GTPase cycle,0.05707917910126965
MAP2K and MAPK activation,0.043828511477286725
Signaling by moderate kinase activity BRAF mutants,0.03695035110540164
Signaling by high-kinase activity BRAF mutants,0.004043297599139656
Signaling by RAS mutants,0.0036500559628838748
Signaling by BRAF and RAF1 fusions,-0.038614262224847797
Paradoxical activation of RAF signaling by kinase inactive BRAF,0.009071576462413173
Oncogenic MAPK signaling,-0.01958852563836544
Signaling downstream of RAS mutants,0.008015430582209125
Signaling by RAF1 mutants,0.022046702708369597
AKT phosphorylates targets in the cytosol,-0.005398715979988931
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,-0.00689882561162314
"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",0.03975698600376398
Diseases of mitotic cell cycle,-0.010710623005157212
FLT3 signaling in disease,-0.01684954505726339
Aberrant regulation of mitotic cell cycle due to RB1 defects,0.020334735934650714
Signaling by ALK in cancer,-0.010842867958530301
Signaling by FLT3 ITD and TKD mutants,-0.0084601736764259
Signaling by ALK fusions and activated point mutants,-0.0637251200346717
RHO GTPases activate CIT,0.007639029907979286
Extra-nuclear estrogen signaling,0.0015945741274483024
Estrogen-dependent nuclear events downstream of ESR-membrane signaling,0.005851727442597687
Signaling by Activin,0.004175051343361571
Downregulation of TGF-beta receptor signaling,-0.025577849670190663
TGF-beta receptor signaling activates SMADs,0.02349013468885603
G alpha (z) signalling events,-0.06210005774375084
Activation of RAC1,-0.004519511458145479
RHOQ GTPase cycle,-0.072837602640488
RHOH GTPase cycle,-0.04495488285881271
RHOG GTPase cycle,-0.027553135081995157
RHOJ GTPase cycle,0.09615584446598746
RHOV GTPase cycle,-0.020478389256269
Signaling by Insulin receptor,-0.0003591166087120516
Insulin receptor recycling,0.007120011439598112
MET activates PTK2 signaling,-0.0009578423485446572
MET promotes cell motility,-0.10897355452181731
MTOR signalling,0.00016966450445794987
mTORC1-mediated signalling,-0.00029401160147949246
Energy dependent regulation of mTOR by LKB1-AMPK,0.00635241526513194
Diseases of Immune System,0.04450521904832083
Diseases associated with the TLR signaling cascade,-0.0012276920543179456
RHO GTPases activate IQGAPs,0.016997174350884943
RHO GTPases Activate Formins,0.07007397697698775
RHO GTPases activate PKNs,-0.035678223744625114
RHO GTPases Activate ROCKs,-0.018628886421042636
RHO GTPases activate PAKs,-0.039012161316957804
Aberrant regulation of mitotic exit in cancer due to RB1 defects,0.0022619147852519826
Pre-NOTCH Processing in Golgi,0.02065273191600691
Signaling by ERBB4,-0.008795985422607133
Nuclear signaling by ERBB4,0.0004232382056922859
Signaling by Hippo,0.01944305658140629
RHOD GTPase cycle,-0.02517442604002648
SARS-CoV-1-host interactions,-0.06962125863825776
SARS-CoV-1 activates/modulates innate immune responses,-0.011629078608186913
RND3 GTPase cycle,0.0613621914807963
Nuclear events stimulated by ALK signaling in cancer,-0.023150476169308397
HCMV Late Events,-0.0381967313539356
Formation of the beta-catenin:TCF transactivating complex,0.14867627362210764
Peptide ligand-binding receptors,-0.0073851012095114115
Chemokine receptors bind chemokines,0.019552142838843295
Translation of Structural Proteins,-0.0011860379747047109
Maturation of spike protein,0.04516039593313897
Late SARS-CoV-2 Infection Events,-0.11767997706085936
Purinergic signaling in leishmaniasis infection,-0.0007002149716509886
Cell recruitment (pro-inflammatory response),0.039926011304832025
CaMK IV-mediated phosphorylation of CREB,-0.007556285555241228
Calmodulin induced events,-0.005705947617311855
Ca-dependent events,0.004151458792284657
CaM pathway,-0.004643039987384481
G-protein mediated events,0.025307755873667265
PLC beta mediated events,-0.03141154590210901
DAG and IP3 signaling,0.00991530418121231
G-protein activation,-0.0024166645051582423
Ca2+ pathway,-0.03601735482482347
G beta:gamma signalling through PLC beta,0.0017847286019653716
Glucagon-type ligand receptors,0.12831041510653862
G beta:gamma signalling through BTK,-0.04836641634243805
G beta:gamma signalling through CDC42,-0.012841174378678521
GPER1 signaling,0.0057820860509913774
ADORA2B mediated anti-inflammatory cytokines production,-0.013999722084844436
Anti-inflammatory response favouring Leishmania parasite infection,-0.028503941456027544
Leishmania parasite growth and survival,-0.021743897751913644
PKA-mediated phosphorylation of CREB,-0.023250995998743716
PKA activation,0.027030191495268696
Adenylate cyclase activating pathway,0.019235426222632742
Adenylate cyclase inhibitory pathway,-0.009218271635472335
FCGR3A-mediated IL10 synthesis,-0.03280623231539421
Signaling by ERBB2 in Cancer,0.009880348608620729
Constitutive Signaling by Aberrant PI3K in Cancer,0.02800493941733476
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",-0.04094890760336588
Signaling by ERBB2 KD Mutants,-0.00037105735055290506
Signaling by ERBB2 TMD/JMD mutants,0.010147861098122947
RND2 GTPase cycle,0.01987463260082977
Signaling by TGFBR3,0.011361214466263762
Rev-mediated nuclear export of HIV RNA,-0.01170116008305874
Transport of Ribonucleoproteins into the Host Nucleus,-0.004093782593896015
Export of Viral Ribonucleoproteins from Nucleus,-0.01193475400696959
NS1 Mediated Effects on Host Pathways,-0.010196502822179647
Viral Messenger RNA Synthesis,0.015453197459542593
NEP/NS2 Interacts with the Cellular Export Machinery,-0.007260418242378405
Interactions of Vpr with host cellular proteins,0.048508468066541244
Interactions of Rev with host cellular proteins,0.0036413988708452237
Nuclear import of Rev protein,-0.08103233859123107
Vpr-mediated nuclear import of PICs,-0.0013635537235240024
SLC transporter disorders,-0.05549909810902896
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC),-0.0228532361210981
VEGFR2 mediated cell proliferation,-0.003439043192013614
Eicosanoid ligand-binding receptors,-0.02011390643077842
RHO GTPases Activate NADPH Oxidases,-0.001141716880917863
Downstream signaling of activated FGFR1,-0.012638508581067427
FRS-mediated FGFR1 signaling,-0.0001165107999232364
Downstream signaling of activated FGFR2,0.0026288985918956815
FRS-mediated FGFR2 signaling,0.003436251864475982
FRS-mediated FGFR3 signaling,-0.002808559208966748
Downstream signaling of activated FGFR3,-0.022350549339700113
FRS-mediated FGFR4 signaling,-0.01973377020072405
Downstream signaling of activated FGFR4,-0.019558285151219105
RND1 GTPase cycle,-0.10465174578549984
Signaling by FGFR in disease,0.014475886132587967
Prolonged ERK activation events,-0.0018463438131452734
Frs2-mediated activation,0.008812303782362762
Signalling to ERKs,-0.06335737478273303
Signaling by ALK,-0.023692400565383704
Signaling by FGFR2 in disease,-0.05563863429253102
Signaling by FGFR1 in disease,-0.006596274446128703
Signaling by FGFR3 in disease,0.010557937264201808
SARS-CoV-1 targets host intracellular signalling and regulatory pathways,0.004184965033797573
Activation of SMO,-0.005483631621609874
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,0.01995799379298971
Signaling by EGFR in Cancer,0.006965284573760473
Constitutive Signaling by EGFRvIII,0.00038183829026521655
Signaling by EGFRvIII in Cancer,0.015187927600323073
Signaling by Ligand-Responsive EGFR Variants in Cancer,0.03433155806704266
Signaling by ERBB2 ECD mutants,0.015265210702571561
Infection with Mycobacterium tuberculosis,-0.007845125783677444
Response of Mtb to phagocytosis,-0.013556889923308122
Signaling by BMP,-0.011492531814989625
Early Phase of HIV Life Cycle,-0.007021154199691113
SARS-CoV-2 modulates host translation machinery,-0.017331717804554597
RAF-independent MAPK1/3 activation,-0.010439594137032835
Negative regulation of MAPK pathway,0.003829649263309615
Viral mRNA Translation,-0.02089114794977819
Amine ligand-binding receptors,-0.01118505677088882
Neurotoxicity of clostridium toxins,0.028649967311489548
SARS-CoV-2 modulates autophagy,-0.009779913643825085
PI3K Cascade,-0.05293575874899862
IRS-mediated signalling,-0.006018759491249488
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),0.03111742871276212
IGF1R signaling cascade,-0.024243608771046674
IRS-related events triggered by IGF1R,-0.01041905919575299
Insulin receptor signalling cascade,-0.014118868363408059
WNT5A-dependent internalization of FZD4,0.02477873122791761
"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",-0.017546923963369158
Induction of Cell-Cell Fusion,-0.06171708480844694
Signaling by PDGF,0.061484680230081884
Translation of Replicase and Assembly of the Replication Transcription Complex,0.037189883527004794
Early SARS-CoV-2 Infection Events,0.007368068406269265
Assembly Of The HIV Virion,-0.028377844115953555
Evasion by RSV of host interferon responses,0.013553098058490119
Downstream signal transduction,0.005777246510525537
p130Cas linkage to MAPK signaling for integrins,-0.010077758813101443
Signaling by Erythropoietin,0.05599747097569497
SARS-CoV-1 modulates host translation machinery,-0.005265767415258248
Downregulation of SMAD2/3:SMAD4 transcriptional activity,-0.013252810229466387
Maturation of nucleoprotein,0.014375527588831405
Signalling to RAS,0.002081342604674137
FGFR2 ligand binding and activation,-0.003490865695537673
Signaling by WNT in cancer,-0.01180776151738742
Signaling by AXIN mutants,0.026767086438997393
Signaling by CTNNB1 phospho-site mutants,-0.0025768499464372875
Signaling by APC mutants,0.005489002580245971
Signaling by AMER1 mutants,0.005483691752742369
Signaling by GSK3beta mutants,-0.0037473788234010865
CTNNB1 S33 mutants aren't phosphorylated,-0.017644232417095142
CTNNB1 S37 mutants aren't phosphorylated,0.03704949511625167
CTNNB1 S45 mutants aren't phosphorylated,0.003656014122594097
CTNNB1 T41 mutants aren't phosphorylated,0.014175262742490343
APC truncation mutants have impaired AXIN binding,-0.040653832324168054
AXIN missense mutants destabilize the destruction complex,-0.022728316931153198
Truncations of AMER1 destabilize the destruction complex,-0.008413305843713898
"Respiratory syncytial virus (RSV) genome replication, transcription and translation",0.0012644308933830986
Maturation of hRSV A proteins,-0.016904356077443578
RHO GTPases activate KTN1,-0.013877227658765765
Deactivation of the beta-catenin transactivating complex,0.0063455544727604035
Repression of WNT target genes,0.022380069007286545
FGFR4 ligand binding and activation,-0.015291011463486673
Phospholipase C-mediated cascade; FGFR4,0.0013989275147352394
SHC-mediated cascade:FGFR4,0.029918706518118798
PI-3K cascade:FGFR4,0.0015960603322060368
STAT3 nuclear events downstream of ALK signaling,0.01810749188605062
Defective pyroptosis,-0.04400806703477188
ERK/MAPK targets,-0.011082506241816514
ERKs are inactivated,0.01951775915352281
TGFBR3 expression,-0.038072225557171865
Erythropoietin activates Phosphoinositide-3-kinase (PI3K),0.018179684612615255
Class C/3 (Metabotropic glutamate/pheromone receptors),0.1264200736876147
FGFR1 mutant receptor activation,-0.068077168857525
FGFR2 mutant receptor activation,0.03418517953212902
Activated point mutants of FGFR2,0.018798344273779046
Phospholipase C-mediated cascade; FGFR2,-0.010687089799701961
PI-3K cascade:FGFR1,-0.0208497716765772
PI-3K cascade:FGFR2,-0.03073481633548285
SHC-mediated cascade:FGFR2,-0.004498513096218224
Signaling by FGFR2 IIIa TM,-0.005623316168709938
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),-0.001370738683082299
Abortive elongation of HIV-1 transcript in the absence of Tat,0.031854045867812944
FGFR2 alternative splicing,0.010068351888446844
Regulation of PTEN mRNA translation,0.016324030428966865
Competing endogenous RNAs (ceRNAs) regulate PTEN translation,0.01799847264387547
NRIF signals cell death from the nucleus,-0.001337642777379245
Signaling by KIT in disease,-0.020220097934552622
"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",-0.013702848386145437
Loss of function of MECP2 in Rett syndrome,0.0021273647631855973
Pervasive developmental disorders,-0.005289345987377134
Disorders of Developmental Biology,0.013370994186369728
Disorders of Nervous System Development,0.019474264170806662
Defects in vitamin and cofactor metabolism,0.001735742791059853
Regulation of FZD by ubiquitination,-0.03961003236055515
Serotonin receptors,-0.0015325648024455312
p75NTR signals via NF-kB,0.001969593033901497
Signaling by NTRK3 (TRKC),-0.002981225155586496
RAF activation,0.0025176348258467906
p75NTR regulates axonogenesis,0.006992421359269357
WNT ligand biogenesis and trafficking,-0.009255484776446566
